State of Alaska Department of Revenue decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 8.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,947 shares of the company’s stock after selling 1,269 shares during the period. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $5,951,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in HCA. Fortitude Family Office LLC increased its holdings in shares of HCA Healthcare by 90.0% in the third quarter. Fortitude Family Office LLC now owns 152 shares of the company’s stock valued at $65,000 after purchasing an additional 72 shares during the last quarter. Western Financial Corp CA raised its position in shares of HCA Healthcare by 15.7% in the third quarter. Western Financial Corp CA now owns 1,732 shares of the company’s stock valued at $739,000 after purchasing an additional 235 shares during the period. Sanders Morris Harris LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $1,613,000. First Citizens Bank & Trust Co. boosted its holdings in shares of HCA Healthcare by 224.6% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 3,957 shares of the company’s stock worth $1,689,000 after buying an additional 2,738 shares during the period. Finally, Signal Advisors Wealth LLC raised its holdings in HCA Healthcare by 24.3% in the 3rd quarter. Signal Advisors Wealth LLC now owns 7,635 shares of the company’s stock valued at $3,258,000 after acquiring an additional 1,493 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Royal Bank Of Canada raised their price objective on shares of HCA Healthcare from $435.00 to $496.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 7th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Finally, Wells Fargo & Company increased their price objective on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $467.61.
View Our Latest Research Report on HCA
HCA Healthcare Stock Performance
Shares of NYSE HCA traded down $10.11 during midday trading on Friday, reaching $458.39. The company’s stock had a trading volume of 1,725,685 shares, compared to its average volume of 1,335,268. The company has a market cap of $99.24 billion, a P/E ratio of 15.35, a P/E/G ratio of 1.58 and a beta of 1.10. The business’s 50 day moving average price is $426.39 and its two-hundred day moving average price is $419.27. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the business posted $6.84 earnings per share. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. Sell-side analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.
HCA Healthcare Company Profile
HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.
HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.
Featured Articles
- Five stocks we like better than HCA Healthcare
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
- 3 Stocks Delivering Bigger Dividends Despite Market Uncertainty
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
